Cost‐Effectiveness Analysis of Hormone Therapy for Breast Cancer in Japan

Anastrozole was less cost-effective than tamoxifen in Japan. Our findings support clinical practice and suggest that payers and policymakers should promote cost-effective therapies.

Authors

Institutions

Publication Details

Journal
Asia-Pacific Journal of Clinical Oncology
Published
2026-02-13
DOI
https://doi.org/10.1111/ajco.70084
Primary Topic
Estrogen and related hormone effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost‐Effectiveness Analysis of Hormone Therapy for Breast Cancer in Japan

Naoto Nakagawa, Yuta Chiba, Leanne Lai
Asia-Pacific Journal of Clinical Oncology
Estrogen and related hormone effects
article

Cost‐Effectiveness Analysis of Hormone Therapy for Breast Cancer in Japan

Naoto Nakagawa, Yuta Chiba, Leanne Lai
article en

Abstract

Anastrozole was less cost-effective than tamoxifen in Japan. Our findings support clinical practice and suggest that payers and policymakers should promote cost-effective therapies.

Asia-Pacific Journal of Clinical Oncology
Kaohsiung Medical University (TW), Ohu University (JP)
Openalex Percentile: Top 54%
Estrogen and related hormone effects
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cost‐Effectiveness Analysis of Hormone Therapy for Breast Cancer in Japan — Naoto Nakagawa, Yuta Chiba, et al. · Asia-Pacific Journal of Clinical Oncology (2026) | TGRS Research Map | TGRS